| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2003-05-1683 |
| P698 | PubMed publication ID | 12907442 |
| P50 | author | Gianluca Gaidano | Q30303486 |
| Daniela Capello | Q30303491 | ||
| Annunziata Gloghini | Q38322915 | ||
| Antonino Carbone | Q61134450 | ||
| Marco Paulli | Q73293658 | ||
| Alessandro Rambaldi | Q87611485 | ||
| Annarita Conconi | Q88019791 | ||
| Davide Rossi | Q89878155 | ||
| Clara Deambrogi | Q114336634 | ||
| Michaela Cerri | Q114336635 | ||
| Giuliana Muti | Q114435431 | ||
| Enrica Morra | Q114439763 | ||
| Eva Berra | Q114441826 | ||
| Pierluigi Oreste | Q114441838 | ||
| Umberto Magrini | Q114441839 | ||
| P2093 | author name string | Mario Viganò | |
| Giampietro Dotti | |||
| Giovanbattista Ippoliti | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphoproliferative disorders | Q4165484 |
| P304 | page(s) | 3775-3785 | |
| P577 | publication date | 2003-08-07 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Molecular histogenesis of posttransplantation lymphoproliferative disorders | |
| P478 | volume | 102 |
| Q24670564 | A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy |
| Q53606266 | Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders. |
| Q95841150 | Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact |
| Q61906657 | Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas |
| Q36650117 | EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis |
| Q42051829 | EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations. |
| Q36172481 | Epstein Barr virus-associated tumours: an update for the attention of the working pathologist |
| Q38270680 | Epstein-Barr virus and Burkitt lymphoma. |
| Q34270452 | Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. |
| Q45590334 | Epstein-Barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation |
| Q29617969 | Epstein-Barr virus: 40 years on |
| Q45106454 | Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. |
| Q51965000 | Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. |
| Q37697850 | Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness |
| Q44644345 | Genome wide DNA-profiling of HIV-related B-cell lymphomas |
| Q83834090 | Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey |
| Q33640213 | IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter |
| Q40383136 | Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma |
| Q42564555 | Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model |
| Q40531014 | Infections under immunosuppressive therapy following organ transplantation |
| Q35808050 | Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma |
| Q47652333 | Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study |
| Q37824825 | Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options |
| Q36085626 | Mechanisms of B-cell lymphoma pathogenesis |
| Q37858939 | Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. |
| Q36282233 | Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis |
| Q42016255 | Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease |
| Q42137120 | Posttransplant lymphoproliferative disorders |
| Q52992155 | Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection. |
| Q28075701 | Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders |
| Q36944250 | The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas |
| Q34750656 | White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia |
Search more.